1.78
Milestone Pharmaceuticals Inc Azioni (MIST) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Research and Development |
26.30%
3.669
|
4.978 | 3.94 | 3.963 | 2.815 |
Operating Income/Loss |
38.94%
-12.53
|
-20.52 | -12.35 | -9.616 | -9.662 |
Income/Loss From Continuing Operations Before Tax |
37.55%
-12.97
|
-20.76 | -12.36 | -9.439 | -9.363 |
Income/Loss From Continuing Operations After Tax |
37.55%
-12.97
|
-20.76 | -12.36 | -9.439 | -9.363 |
|
37.55%
-12.97
|
-20.76 | -12.36 | -9.439 | -9.363 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Earnings Per Share |
35.48%
-0.20
|
-0.31 | -0.19 | -0.14 | -0.14 |
Diluted Earnings Per Share |
35.48%
-0.20
|
-0.31 | -0.19 | -0.14 | -0.14 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):